Main Article Content


The goal of Ayurveda is prevention is better than cure. There are a total of 9152 COVID-19 cases reported in India (till April 13, 2020), 308 people were died because of this disease, and 856 patients were treated successfully in our Country. This virus can easily affect or harm those individuals who have an infection, less immunity and especially who all have been aged more than sixty. Most of the countries are worried only for their people's life (health). In contrast, the developing countries like India that has a large population have to consider about the livelihood for people like Below Poverty Line (BPL) or those living in slum areas, equally with their life. The main aim of the article is to aware the people not only Urban but also among Rural and needy individuals to adopt the Ayurveda lifestyle during Covid19 outbreak. For this to study various methods which are described in Ayurveda for boosting immunity among various individuals. This study is a review type of article. All information and references have been collected and compiled from various available Ayurvedic classics texts. Research articles are also searched from various websites related to Covid19 outbreak and its effect on needy individuals. All matters have been analysed for some discussion, and an attempt has been made to rule out some conclusions. During this lockdown, people are mostly living a sedentary lifestyle which not only weakens their immune system but also make them more susceptible to infections. Hence Ayurveda is a science of life that is mainly focusing on strengthening persons by boosting their immune system through improving our lifestyle by using medicines, diets, meditation and activities like Yoga. This article will give insights about poor people and effective strategy to threat COVID-19 through Ayurveda in India.


Ayurveda Immunity Rural Sedentary life Urban Virus

Article Details

How to Cite
Anuradha Kishor Ingale, & Pooja Shrivastav. (2020). Role of Ayurveda for Poor and Pandemics (Covid19) – A Review article. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 923-927.